找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Discovery and Evaluation: Methods in Clinical Pharmacology; Franz J. Hock,Michael R. Gralinski Living reference work 20200th edition

[復制鏈接]
樓主: HBA1C
21#
發(fā)表于 2025-3-25 05:47:35 | 只看該作者
22#
發(fā)表于 2025-3-25 08:48:09 | 只看該作者
Experimental Methods for Evaluating Pharmacodynamic Effects of Drugs for the Pulmonary System,ical research although they lack many features of the human condition. The primary characteristic of COPD that is replicated in animal models is non-allergic inflammation. The main challenge with this is that COPD often develops over a significant period of time which is difficult to accurately repl
23#
發(fā)表于 2025-3-25 15:24:52 | 只看該作者
Food Supplements: Definition and Classification, cases contain low-dosed drugs, delimitation questions occur frequently..Hence the issue, whether some of these products are to be classified as medicinal products and how they are to be differentiated..Subsequently, we would like to introduce the basic requirements to put those food supplements leg
24#
發(fā)表于 2025-3-25 16:02:43 | 只看該作者
25#
發(fā)表于 2025-3-25 19:58:33 | 只看該作者
26#
發(fā)表于 2025-3-26 02:36:15 | 只看該作者
In silico Drug Repositioning Using Omics Data: The Potential and Pitfalls,hese tools, possible applications, and how different inputs can influence results is essential in order that users can maximize the potential of such in silico analyses. This in turn will accelerate the preclinical stage of the biomarker translational pipeline, often perceived as a key bottleneck.
27#
發(fā)表于 2025-3-26 06:09:40 | 只看該作者
28#
發(fā)表于 2025-3-26 12:18:36 | 只看該作者
29#
發(fā)表于 2025-3-26 16:29:08 | 只看該作者
Helen Austerberry,Sophie Watsont of this Guideline but introduced technology and approaches that were unknown when the GCP Guideline got issued for the first time. Twenty years ago clinical development was largely a paper-based process, and the Internet and even more so the . were technology and tools only known to a few ..
30#
發(fā)表于 2025-3-26 19:27:39 | 只看該作者
Clinical Pharmacology of Tinnitus: Design and Evaluation,at should be taken under consideration when designing clinical pharmacological study for tinnitus is presented in an anticipation to help design trials producing meaningful clinical data and identifying clinically relevant substances effective in tinnitus treatment.
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 09:43
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
墨玉县| 南宁市| 河曲县| 嫩江县| 二连浩特市| 开江县| 新乡县| 常德市| 马山县| 安溪县| 南京市| 勐海县| 新和县| 鄄城县| 赤峰市| 睢宁县| 潮安县| 永安市| 北票市| 安图县| 望谟县| 会理县| 西乡县| 安阳市| 石台县| 东安县| 老河口市| 板桥市| 铜陵市| 香港 | 静安区| 海南省| 股票| 麻城市| 荔波县| 永胜县| 湘阴县| 剑阁县| 佛学| 古蔺县| 崇礼县|